Xavier Lebreton

499 total citations
9 papers, 330 citations indexed

About

Xavier Lebreton is a scholar working on Transplantation, Epidemiology and Nephrology. According to data from OpenAlex, Xavier Lebreton has authored 9 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 4 papers in Epidemiology and 3 papers in Nephrology. Recurrent topics in Xavier Lebreton's work include Renal Transplantation Outcomes and Treatments (6 papers), Cytomegalovirus and herpesvirus research (4 papers) and Renal Diseases and Glomerulopathies (2 papers). Xavier Lebreton is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Cytomegalovirus and herpesvirus research (4 papers) and Renal Diseases and Glomerulopathies (2 papers). Xavier Lebreton collaborates with scholars based in France, Belgium and Canada. Xavier Lebreton's co-authors include Dany Anglicheau, Christophe Legendre, Marion Rabant, Virginia Sauvaget, Lucile Amrouche, Fabiola Terzi, Lise Morin, Florence Aulagnon, Anne Scemla and Marc‐Olivier Timsit and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and Frontiers in Immunology.

In The Last Decade

Xavier Lebreton

9 papers receiving 330 citations

Peers

Xavier Lebreton
Erik Stites United States
Roxana Bologa United States
Reuben D. Sarwal United States
Paul Warner United States
Sourabh Chand United Kingdom
Xavier Lebreton
Citations per year, relative to Xavier Lebreton Xavier Lebreton (= 1×) peers Jeffery M. Venner

Countries citing papers authored by Xavier Lebreton

Since Specialization
Citations

This map shows the geographic impact of Xavier Lebreton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Lebreton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Lebreton more than expected).

Fields of papers citing papers by Xavier Lebreton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Lebreton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Lebreton. The network helps show where Xavier Lebreton may publish in the future.

Co-authorship network of co-authors of Xavier Lebreton

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Lebreton. A scholar is included among the top collaborators of Xavier Lebreton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Lebreton. Xavier Lebreton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tinel, Claire, Daniela Picciotto, Lise Morin, et al.. (2020). Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation. Frontiers in Immunology. 11. 604353–604353. 11 indexed citations
2.
Jouffroy, Romain, Xavier Lebreton, Nicolas Mansencal, & Dany Anglicheau. (2019). Acute kidney injury during an ultra-distance race. PLoS ONE. 14(9). e0222544–e0222544. 17 indexed citations
3.
Devresse, Arnaud, Marianne Leruez‐Ville, Anne Scemla, et al.. (2018). Reduction in late onset cytomegalovirus primary disease after discontinuation of antiviral prophylaxis in kidney transplant recipients treated with de novo everolimus. Transplant Infectious Disease. 20(2). e12846–e12846. 4 indexed citations
4.
See, Sarah B., Olivier Aubert, Alexandre Loupy, et al.. (2018). Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival. Journal of the American Society of Nephrology. 29(6). 1761–1770. 27 indexed citations
5.
Devresse, Arnaud, Lise Morin, Florence Aulagnon, et al.. (2018). Baseline graft status is a critical predictor of kidney graft failure after diarrhoea. Nephrology Dialysis Transplantation. 34(9). 1597–1604. 2 indexed citations
6.
Amrouche, Lucile, Marion Rabant, Virginia Sauvaget, et al.. (2016). MicroRNA-146a in Human and Experimental Ischemic AKI: CXCL8-Dependent Mechanism of Action. Journal of the American Society of Nephrology. 28(2). 479–493. 78 indexed citations
7.
Rabant, Marion, Lucile Amrouche, Lise Morin, et al.. (2015). Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients. American Journal of Transplantation. 16(6). 1868–1881. 54 indexed citations
8.
Rabant, Marion, Lucile Amrouche, Xavier Lebreton, et al.. (2015). Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody–Mediated Kidney Allograft Rejection. Journal of the American Society of Nephrology. 26(11). 2840–2851. 110 indexed citations
9.
Chemouny, Jonathan, Caroline Suberbielle, Marion Rabant, et al.. (2014). De Novo Donor-Specific Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients After T Cell-Mediated Rejection. Transplantation. 99(5). 965–972. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026